ABO blood type, long-standing diabetes, and the risk of pancreatic cancer

World Journal of Gastroenterology

Volumn 19, Issue 16, 2013, Pages 2537-2542

  Egawa, Naoto ^a,b   Lin, Yingsong ^c   Tabata, Taku ^a   Kuruma, Sawako ^a   Hara, Seiichi ^a   Kubota, Ken ^a   Kamisawa, Terumi ^a  

^a TOKYO METROPOLITAN KOMAGOME HOSPITAL   (Japan)

^b TOKYO METROPOLITAN MATSUZAWA HOSPITAL   (Japan)

^c AICHI MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

ABO blood type; Diabetes mellitus; Pancreatic cancer; Risk factor; Screening

Indexed keywords

ADULT; AGE; AGED; ARTICLE; BLOOD GROUP ABO SYSTEM; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; FAMILY HISTORY; FEMALE; GENDER; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS CANCER; RETROSPECTIVE STUDY; RISK FACTOR;

EID: 84877296922     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v19.i16.2537     Document Type: Article

References (27)

1. WHO Mortality Database. Available from: URL: http://www.who.int/healthinfo/morttables/en/index.html
2. Iodice S, Gandini S, Maisonneuve P, Lowenfels AB. To-bacco and the risk of pancreatic cancer: a review and metaanalysis. Langenbecks Arch Surg 2008; 393: 535-545 [PMID: 18193270 DOI: 10.1007/s00423-007-0266-2]
3. Huxley R, Ansary-Moghaddam A, Berrington de González A, Barzi F, Woodward M. Type-II diabetes and pancreatic cancer: a meta-analysis of 36 studies. Br J Cancer 2005; 92: 2076-2083 [PMID: 15886696 DOI: 10.1038/sj.bjc.6602619]
4. Chari ST, Leibson CL, Rabe KG, Timmons LJ, Ransom J, de Andrade M, Petersen GM. Pancreatic cancer-associated diabetes mellitus: prevalence and temporal association with diagnosis of cancer. Gastroenterology 2008; 134: 95-101 [PMID: 18061176 DOI: 10.1053/j.gastro.2007.10.040]
5. Pannala R, Basu A, Petersen GM, Chari ST. New-onset diabetes: a potential clue to the early diagnosis of pancreatic cancer. Lancet Oncol 2009; 10: 88-95 [PMID: 19111249 DOI:10.1016/S1470-2045(08)70337-1]
6. Roberts JA. Blood groups and susceptibility to disease: a review. Br J Prev Soc Med 1957; 11: 107-125 [PMID: 13471902]
7. Moniwa H. Statistical studies on the correlation between the ABO-blood groups and some diseases. Tohoku J Exp Med 1960; 72: 275-289 [PMID: 13772037 DOI: 10.1620/tjem.72.275]
8. Xie J, Qureshi AA, Li Y, Han J. ABO blood group and incidence of skin cancer. PLoS One 2010; 5: e11972 [PMID: 20694147 DOI: 10.1371/journal.pone.0011972]
9. Caygill CP, Royston C, Charlett A, Wall CM, Gatenby PA, Ramus JR, Watson A, Winslet M, Hourigan CS, Dev Bardhan K. Barrett's, blood groups and progression to oesophageal cancer: is nitric oxide the link? Eur J Gastroenterol Hepatol 2011; 23: 801-806 [PMID: 21701391 DOI: 10.1097/MEG. 0b013e3283489dcf]
10. Li Q, Yu CH, Yu JH, Liu L, Xie SS, Li WW, Yang X, Fan WB, Gai ZT, Chen SJ, Kato N. ABO blood group and the risk of hepatocellular carcinoma: a case-control study in patients with chronic hepatitis B. PLoS One 2012; 7: e29928 [PMID: 22235351 DOI: 10.1371/journal.pone.0029928]
11. Wolpin BM, Chan AT, Hartge P, Chanock SJ, Kraft P, Hunter DJ, Giovannucci EL, Fuchs CS. ABO blood group and the risk of pancreatic cancer. J Natl Cancer Inst 2009; 101: 424-431 [PMID: 19276450 DOI: 10.1093/dnci/djp020]
12. Wolpin BM, Kraft P, Gross M, Helzlsouer K, Bueno-de Mesquita HB, Steplowski E, Stolzenberg-Solomon RZ, Arslan AA, Jacobs EJ, Lacroix A, Petersen G, Zheng W, Albanes D, Allen NE, Amundadottir L, Anderson G, Boutron-Ruault MC, Buring JE, Canzian F, Chanock SJ, Clipp S, Gaziano JM, Giovannucci EL, Hallmans G, Hankinson SE, Hoover RN, Hunter DJ, Hutchinson A, Jacobs K, Kooperberg C, Lynch SM, Mendelsohn JB, Michaud DS, Overvad K, Patel AV, Rajkovic A, Sanchéz MJ, Shu XO, Slimani N, Thomas G, Tobias GS, Trichopoulos D, Vineis P, Virtamo J, Wactawski-Wende J, Yu K, Zeleniuch-Jacquotte A, Hartge P, Fuchs CS. Pancreatic cancer risk and ABO blood group alleles: results from the pancreatic cancer cohort consortium. Cancer Res 2010; 70: 1015-1023 [PMID: 20103627 DOI: 10.1158/0008-5472.CAN-09-2993]
13. Greer JB, Yazer MH, Raval JS, Barmada MM, Brand RE, Whitcomb DC. Significant association between ABO blood group and pancreatic cancer. World J Gastroenterol 2010; 16: 5588-5591 [PMID: 21105191 DOI: 10.3748/wjg.v16.i44.5588]
14. Nakao M, Matsuo K, Hosono S, Ogata S, Ito H, Watanabe M, Mizuno N, Iida S, Sato S, Yatabe Y, Yamao K, Ueda R, Tajima K, Tanaka H. ABO blood group alleles and the risk of pancreatic cancer in a Japanese population. Cancer Sci 2011; 102: 1076-1080 [PMID: 21306478 DOI: 10.1111/j.13497006.2011.01907x]
15. Ben Q, Wang K, Yuan Y, Li Z. Pancreatic cancer incidence and outcome in relation to ABO blood groups among Han Chinese patients: a case-control study. Int J Cancer 2011; 128: 1179-1186 [PMID: 20473916 DOI: 10.1002/ijc.25426]
16. Amundadottir L, Kraft P, Stolzenberg-Solomon RZ, Fuchs CS, Petersen GM, Arslan AA, Bueno-de-Mesquita HB, Gross M, Helzlsouer K, Jacobs EJ, LaCroix A, Zheng W, Albanes D, Bamlet W, Berg CD, Berrino F, Bingham S, Buring JE, Bracci PM, Canzian F, Clavel-Chapelon F, Clipp S, Cotterchio M, de Andrade M, Duell EJ, Fox JW Jr, Gallinger S, Gaziano JM, Giovannucci EL, Goggins M, González CA, Hallmans G, Hankinson SE, Hassan M, Holly EA, Hunter DJ, Hutchinson A, Jackson R, Jacobs KB, Jenab M, Kaaks R, Klein AP, Kooperberg C, Kurtz RC, Li D, Lynch SM, Mandelson M, McWilliams RR, Mendelsohn JB, Michaud DS, Olson SH, Overvad K, Patel AV, Peeters PH, Rajkovic A, Riboli E, Risch HA, Shu XO, Thomas G, Tobias GS, Trichopoulos D, Van Den Eeden SK, Virtamo J, Wactawski-Wende J, Wolpin BM, Yu H, Yu K, Zeleniuch-Jacquotte A, Chanock SJ, Hartge P, Hoover RN. Genome-wide association study identifies variants in the ABO locus associated with susceptibility to pancreatic cancer. Nat Genet 2009; 41: 986-990 [PMID: 19648918 DOI: 10.1038/ng.429]
17. Fujita Y, Tanimura M, Tanaka K. The distribution of the ABO blood groups in Japan. Jinrui Idengaku Zasshi 1978; 23: 63-109 [PMID: 691841 DOI: 10.1007/BF02001790]
18. Jee SH, Ohrr H, Sull JW, Yun JE, Ji M, Samet JM. Fasting serum glucose level and cancer risk in Korean men and women. JAMA 2005; 293: 194-202 [PMID: 15644546 DOI: 10.1001/jama.293.2.194]
19. Qi L, Cornelis MC, Kraft P, Jensen M, van Dam RM, Sun Q, Girman CJ, Laurie CC, Mirel DB, Hunter DJ, Rimm E, Hu FB. Genetic variants in ABO blood group region, plasma soluble E-selectin levels and risk of type 2 diabetes. Hum Mol Genet 2010; 19: 1856-1862 [PMID: 20147318 DOI: 10.1093/ hmg/ddq057]
20. Paré G, Chasman DI, Kellogg M, Zee RY, Rifai N, Badola S, Miletich JP, Ridker PM. Novel association of ABO histo-blood group antigen with soluble ICAM-1: results of a genome wide association study of 6,578 women. PLoS Genet 2008; 4: e1000118 [PMID: 18604267 DOI: 10.1371/journal.pgen.1000118]
21. Paterson AD, Lopes-Virella MF, Waggott D, Boright AP, Hosseini SM, Carter RE, Shen E, Mirea L, Bharaj B, Sun L, Bull SB, Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group. Genome-wide association identifies the ABO blood group as a major locus associated with serum levels of soluble E-selectin. Arterioscler Thromb Vasc Biol 2009; 29: 1958-1967 [PMID: 19729612 DOI: 10.1161/ATVBAHA. 109.192971]
22. Barbalic M, Dupuis J, Dehghan A, Bis JC, Hoogeveen RC, Schnabel RB, Nambi V, Bretler M, Smith NL, Peters A, Lu C, Tracy RP, Aleksic N, Heeriga J, Keaney JF Jr, Rice K, Lip GY, Vasan RS, Glazer NL, Larson MG, Uitterlinden AG, Yamamoto J, Durda P, Haritunians T, Psaty BM, Boerwinkle E, Hofman A, Koenig W, Jenny NS, Witteman JC, Ballantyne C, Benjamin EJ. Large-scale genomic studies reveal central role of ABO in sP-selectin and sICAM-1 levels. Hum Mol Genet 2010; 19: 1863-1872 [PMID: 20167578 DOI: 10.1093/hmg/ ddq061]
23. Meigs JB, Hu FB, Rifai N, Manson JE. Biomarkers of endothelial dysfunction and risk of type 2 diabetes mellitus. JAMA 2004; 291: 1978-1986 [PMID: 15113816 DOI: 10.1001/ jama.291.16.1978]
24. Song Y, Manson JE, Tinker L, Rifai N, Cook NR, Hu FB, Hotamisligil GS, Ridker PM, Rodriguez BL, Margolis KL, Oberman A, Liu S. Circulating levels of endothelial adhesion molecules and risk of diabetes in an ethnically diverse cohort of women. Diabetes 2007; 56: 1898-1904 [PMID: 17389327 DOI: 10.2337/db07-0250]
25. Melzer D, Perry JR, Hernandez D, Corsi AM, Stevens K, Rafferty I, Lauretani F, Murray A, Gibbs JR, Paolisso G, Rafiq S, Simon-Sanchez J, Lango H, Scholz S, Weedon MN, Arepalli S, Rice N, Washecka N, Hurst A, Britton A, Henley W, van de Leemput J, Li R, Newman AB, Tranah G, Harris T, Panicker V, Dayan C, Bennett A, McCarthy MI, Ruokonen A, Jarvelin MR, Guralnik J, Bandinelli S, Frayling TM, Singleton A, Ferrucci L. A genome-wide association study identifies protein quantitative trait loci (pQTLs). PLoS Genet 2008; 4: e1000072 [PMID: 18464913 DOI: 10.1371/journal.pgen. 1000072]
26. Garcea G, Dennison AR, Steward WP, Berry DP. Role of inflammation in pancreatic carcinogenesis and the implications for future therapy. Pancreatology 2005; 5: 514-529 [PMID: 16110250 DOI: 10.1159/000087493]
27. Mishima Y, Kuyama A, Tada A, Takahashi K, Ishioka T, Kibata M. Relationship between serum tumor necrosis factor-alpha and insulin resistance in obese men with Type 2 diabetes mellitus. Diabetes Res Clin Pract 2001; 52: 119-123 [PMID: 11311966 DOI: 10.1016/S0168-8277(00)00247-3]